Literature DB >> 993209

Impermeant maleimides. Oriented probes of erythrocyte membrane proteins.

R E Abbott, D Schachter.   

Abstract

Maleimides impermeant to human erythrocyte membranes have been synthesized and applied to studies of the sulfhydryl groups of the membrane. Reaction of radioactive dextran-maleimide and glutathione-maleimide with either intact erythrocytes or ghosts yields sulfhydryl titers for the outer (exofacial) and inner (endofacial) surfaces, respectively, of 1.5 to 1.7 and 27 to 28 amol/cell. Corresponding values for sulfhydryl groups within the membrane interior, as estimated with radioactive N-ethylmaleimide, are 16 to 22 amol/cell. After exofacial labeling of intact cells with [35S]glutathione-maleimide, autoradiography of sodium dodecyl sulfate-polyacrylamide gels demonstrates four bands (alpha, beta, gamma, and delta) containing, respectively, 13%, 63%, 11%, and 13% of the radioactivity. The major beta-band corresponds in position to polypeptides of molecular weight 40,000 to 70,000 and to Coomassie brilliant blue-stained Band 5. Selective extraction demonstrates that the major Band 5 protein is not identical with the labeled beta-band polypeptides. Following endofacial labeling of ghosts with [35S]glutathione-maleimide, autoradiography reveals radioactivity in all of the major Coomassie brilliant blue bands. The impermeant maleimides described are also applicable to studies of discrete functional proteins of the erythrocyte membrane, including the hexose transport mechanism and the major Rho antigenic site.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 993209

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)-blood-group-antigen expression.

Authors:  N D Avent; K Ridgwell; M J Tanner; D J Anstee
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

Review 2.  Permeabilization of transformed cells in culture by external ATP.

Authors:  L A Heppel; G A Weisman; I Friedberg
Journal:  J Membr Biol       Date:  1985       Impact factor: 1.843

Review 3.  Monocarboxylate transport in erythrocytes.

Authors:  B Deuticke
Journal:  J Membr Biol       Date:  1982       Impact factor: 1.843

4.  Concentration and reactivity of the sulphydryl group population on the membrane of intact erythrocytes in patients with rheumatoid arthritis.

Authors:  C Chilles; M Mulheron; F M McCrae; J Reglinksi; W E Smith; M Brzeski; R D Sturrock
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

5.  Thiol-dependent passive K/Cl transport in sheep red cells: VII. Volume-independent freezing by iodoacetamide, and sulfhydryl group heterogeneity.

Authors:  P K Lauf
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

6.  Topography and functions of sulfhydryl groups of the human erythrocyte glucose transport mechanism.

Authors:  R E Abbott; D Schachter
Journal:  Mol Cell Biochem       Date:  1988 Jul-Aug       Impact factor: 3.396

7.  Absence of two membrane proteins containing extracellular thiol groups in Rhnull human erythrocytes.

Authors:  K Ridgwell; S J Roberts; M J Tanner; D J Anstee
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

8.  Inhibition of hexose transport and labelling of the hexose carrier in human erythrocytes by an impermeant maleimide derivative of maltose.

Authors:  J M May
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

9.  Evidence for inhibitory SH groups in the thiol activated K:Cl cotransporter of low K sheep red blood cells.

Authors:  K H Ryu; P K Lauf
Journal:  Mol Cell Biochem       Date:  1990-12-20       Impact factor: 3.396

10.  The sulfhydryl groups of the 35,000-dalton C-terminal segment of band 3 are located in a 9000-dalton fragment produced by chymotrypsin treatment of red cell ghosts.

Authors:  M Ramjeesingh; A Gaarn; A Rothstein
Journal:  J Bioenerg Biomembr       Date:  1981-12       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.